ABDSEROTEC search AbDSerotec IFNG products
includes other brands or spellings
|
| flow | | Serotec anti-IFN-gamma-FITC antibody was used in PBMCs from human and in flow cytometry to study the cell-specific Th1 (IL-12, IFN-γ, TNF-α) and Th2 (IL-4) type cytokine production in peripheral blood mononuclear cells isolated from normal pregnant women. |
R & D SYSTEMS search R & D Systems IFNG products
includes other brands or spellings
|
| block | | R&D Systems neutralizing goat-anti-human IFN-gamma (AF-285-NA) antibody was used to study the proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. |
| elisa | | R&D Systems hIFN-gamma Quantikine kit was used in ELISA to molecularly investigate a patient with a novel form of complete IL-12Rbeta1 deficiency despite the presence of IL-12Rbeta1 at the cell surface. |
BD BIOSCIENCES search BD Biosciences IFNG products
includes other brands or spellings
|
| elisa | | BD Pharmingen IFN gamma antibody was used to study airway smooth muscle function modulation. |
| elisa | | BD Biosciences FITC-coupled anti–hIFN-gamma was used in ELISA to determine IFN-gamma levels in human T cell culture supernatants. |
| elisa | | Pharmingen anti-IFN-γ antibody (which was in ELISA OptEIA antibody pair kits) was used in venous blood from human and in ELISA to study the cytokine production in CMC patients. |
| flow | | PharMingen monoclonal FITC-labeled anti-IFN-gamma antibody was used in CD8+ T cells from human and in ELISPOT assay to study the correlation of cancer with antibody responses. |
| flow | | BD Pharmingen monoclonal anti-IFN-gamma antibody was used in cells from human peripheral blood and in flow cytometry to study the identification of an SSX-2–derived immunodominant T cell epitope recognized by CD4+ T cells from melanoma patients in association with HLA-DR. |
| flow | | Pharmingen FITC-conjugated anti-IFN-gamma monoclonal antibody was used in flow cytometry to study the eotaxin receptor CCR3 expression in CD30+ cutaneous T-cell lymphoma. |
| flow | | BD Biosciences anti-IFN-gamma antibody was used in FACS analysis to study CD1d and invariant NKT cells at the human maternal-fetal interface. |
| flow | | BD PharMingen monoclonal PE-conjugated anti-human IFN-gamma was used in flow cytometry to study the significant alterations constructs induced in expression of IFN-gamma. |
| ic | | Becton-Dickinson monoclonal fastImmune anti-Hu-IFN-gamma antibody was used in HVS-transformed T cell lines from human and in immunocytometry to study the characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients. |
| ih, wb | | Pharmingen mouse anti-human IFN-g antibody (clone B27) was used in western blot and immunohistochemistry to study CD99 and CD106 (VCAM-1) expression in human testis. |
| wb | | BD APC-labeled anti-human IFN gamma antibody was used to study the lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. |
ABCAM search Abcam IFNG products
includes other brands or spellings
|
| block | | Abcam Ltd. mouse monoclonal anti-human IFN-gamma neutralizing antibody F12 (Ab 8096) was used in human choriocarcinoma cell line JEG-3 and in blocking expriments to study the role of interleukin (IL) 12 in regulating trophoblast invasion and the expression of trophoblast proteases using an in vitro tissue culture system of human choriocarcinoma cell line JEG-3. |
MILLIPORE search Millipore IFNG products
includes other brands or spellings
|
| wb | | Chemicon polyclonal antibody to interferon-gamma (IFNgamma) was used in western blot to study the specific binding of human interleukin 3 to a chondroitin sulfate proteoglycan isolated from adult rat brain and the modeling of its carbohydrate recognition domain (CRD). |
INVITROGEN search Invitrogen IFNG products
includes other brands or spellings
|
| elisa | | BioSource Europe SA anti-IFN-γ antibody (which was in ELISA kit) was used in venous blood samples from human and in ELISA to study the association of serum levels of some proinflammatory cytokines in vivo and their correlation with severity of psoriasis. |
EBIOSCIENCE search eBioscience IFNG products
includes other brands or spellings
|
| flow | | Staining was with anti-IFNγ XMG1.2-APC (eBioscience) .). |
BENDER SYSTEMS
|
| elisa | | Bender Systems IFN gamma ELISA ket was used to study inflammatory response induced by glucan. |
ENDOGEN
|
| elisa | | Endogen IFN-gamma ELISA assay was used to study the antigen-specific immunity in neuroblastoma patients. |
ENDOGEN INC
|
| elisa | | Endogen Inc. polyclonal anti-human IFN-gamma antibody was used in human choriocarcinoma cell line JEG-3 and in ELISA to study the role of interleukin (IL) 12 in regulating trophoblast invasion and the expression of trophoblast proteases using an in vitro tissue culture system of human choriocarcinoma cell line JEG-3. |
MABTECH
|
| | | Mabtech monoclonal anti-IFN-gamma antibodies (1-D1K and 7-B6-1-biotin) were used in CD4+ T cells from human and in ELISPOT assays to study the correlation of cancer with antibody responses. |
| | | MABTECH monoclonal anti-IFN-gamma antibodies (1-D1K and 7-B6–1-biotin) were used in CD8+ T cells from human and in ELISPOT assay to study the correlation of cancer with antibody responses. |
| elisa | | Mabtech anti–IFN-gamma antibody (1-D1K) was used in ELISPOT to study the function of fibromodulin which serves as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL) to enable the expansion of specific CD8+ autologous T lymphocytes. |
MABTECH AB
|
| elisa | | Mabtech AB antihuman IFN-gamma antibody (mAb 1-D1K) and biotin-labeled antihuman IFN-gamma antibody (Mab 7-B6–1-Biotin) were used in ELISA to analyze the antigen-specific secretion of IFN-gamma in human dendritic cells generated from adherent peripheral blood mononuclear cells. |
PBL BIOMEDICAL LABORATORIES
|
| elisa | | PBL Biomedical Laboratories monoclonal IFN-gamma antibody was used in ELISA to demonstrate multiple levels of molecular cross-talk between the TRAIL and interferon signaling pathways. |
PELIKIN COMPACT
|
| elisa | | Pelikin Compact IFN-gamma ELISA kit was used in ELISA to molecularly investigate a patient with a novel form of complete IL-12Rbeta1 deficiency despite the presence of IL-12Rbeta1 at the cell surface. |
Articles Reviewed |
| 1. Chandan Kumar-Sinha et al. Molecular cross-talk between the TRAIL and interferon signaling pathways. 2002 |
| 2. J A Cabanillas et al. Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients. 2002 |
| 3. Jean-Pierre Zanetta et al. Evidence for a lectin activity for human interleukin 3 and modeling of its carbohydrate recognition domain. 2002 |
| 4. Sacha Gnjatic et al. CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients. 2002 |
| 5. Jonathan E Boyson et al. CD1d and invariant NKT cells at the human maternal-fetal interface. 2002 |
| 6. Martin Kleinhans et al. Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. 2003 |
| 7. Megan K Levings et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. 2002 |
| 8. E Veräjäkorva et al. CD 99 and CD 106 (VCAM-1) in human testis. 2002 |
| 9. G P Sacks et al. Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. 2003 |
| 10. Sacha Gnjatic et al. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses. 2003 |
| 11. Desa Lilic et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. 2003 |
| 12. Omar Tliba et al. Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. 2003 |
| 13. Monica Rodolfo et al. Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen. 2003 |
| 14. Beata Polgar et al. Molecular cloning and immunologic characterization of a novel cDNA coding for progesterone-induced blocking factor. 2003 |
| 15. Bysani Chandrasekar et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. 2004 |
| 16. Maha Ayyoub et al. An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR. 2004 |
| 17. Kerstin Schag et al. Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes. 2004 |
| 18. Claire Fieschi et al. A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. 2004 |
| 19. Subhradip Karmakar et al. Inhibition of cytotrophoblastic (JEG-3) cell invasion by interleukin 12 involves an interferon gamma-mediated pathway. 2004 |
| 20. Christine Mayr et al. Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 |
| 21. Michael Uhlin et al. Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. 2005 |
| 22. Ozer Arican et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. 2005 |
| 23. Juergen Luhm et al. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio. 2006 |
| 24. Steve H Thorne et al. Synergistic antitumor effects of immune cell-viral biotherapy. 2006 |